Russia's Sputnik V vaccine 'safe, effective': Study
February 3, 2021
Interim results of Phase 3 trial show 91.6% efficacy of 2-dose regimen, according to study published in The Lancet
The Sputnik V coronavirus vaccine developed in Russia has shown “a consistent strong protective effect across all participant age groups,” a...
